NCT04158336 2026-03-18
A Study of Azenosertib (ZN-c3) in Participants With Solid Tumors
K-Group, Beta, Inc., a wholly owned subsidiary of Zentalis Pharmaceuticals, Inc
Phase 1 Completed
Clinical Trials
10 trialsNCT06056024 2026-03-17
A Study to Test How Well Different Doses of BI 3706674 Are Tolerated by People With Advanced Cancer in the Stomach and Oesophagus
Boehringer Ingelheim
Phase 1 Completed
NCT04261413 2026-03-11
Phase Ia/Ib Study of RS-0139 in Patients With a Recurrent, Locally Advanced or Metastatic Solid Tumors
RS Arastirma Egitim Danismanlik Ilac Sanayi Ticaret A.S.
Phase 1 Completed
NCT05735366 2026-03-10
A Phase 1 Study of SAIL66 in Patients With CLDN6-positive Locally Advanced or Metastatic Solid Tumors
Chugai Pharmaceutical
Phase 1 Completed
NCT01761929 2026-03-06
5fr SBRT
University Health Network, Toronto
Phase 2 Completed
NCT00797719 2026-03-05
Short Neoadjuvant Hemithoracic IMRT for MPM
University Health Network, Toronto
Phase 1/2 Completed
NCT05199584 2026-03-05
A Study Evaluating the Safety and Efficacy of ENV-101 (Taladegib) in Patients With Advanced Solid Tumors Harboring PTCH1 Loss of Function Mutations
Endeavor Biomedicines, Inc.
Phase 2 Completed
NCT07449624 2026-03-04
From Presentation to Diagnosis: Patterns of Pleural Effusion
Mansoura University Hospital
Completed
NCT06484595 2026-02-25
GUIDE
Fred Hutchinson Cancer Center
Phase NA Completed
NCT06409000 2026-02-24
Evaluation of 3D Surface Scanning for Virtual-CT Based Radiation Therapy Treatment Planning
Mayo Clinic
Completed